LANREOTIDE

lanreotide 60 mg/0.5 mL injection, 0.5 mL syringe

LANREOTIDE (5777C)

lanreotide 60 mg/0.5 mL injection, 0.5 mL syringe
5777C
Manner of administration:Injection
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction  7025

Indication: Acromegaly

Restriction  4575

Indication: Functional carcinoid tumour
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $1,699.46 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Mytolac
Somatuline Autogel